The 20 Best Anal Cancer Doctors Near Me in Ann Arbor, MI

Dr. Michael McGee is Clinical Associate Professor of Surgery and Chief of the Division of Colorectal Surgery at the University of Michigan. Prior to obtaining his medical degree at Drexel University, he was trained as a mechanical engineer. After completing general surgery training at Case Western Reserve University, Dr. McGee completed colorectal surgery fellowship at Cleveland Clinic. While at Case Western, Dr. McGee completed the Dudley P. Allen Scholarship dedicated to clinical research in minimally invasive surgery and surgical endoscopy. Dr. McGee was recruited to Northwestern University where he practiced for 11 years and held several system-wide administrative roles for Northwestern Medicine before joining the University of Michigan in 2022. Dr. McGee’s clinical interests include complex re-operative abdominal surgery, minimally invasive colorectal surgery, surgical endoscopy, and anorectal surgery for cancer and inflammatory bowel disease. He served as co-director of the 50+ hospital Illinois Surgical Quality Improvement Collaborative (ISQIC) where he led day-to-day operations and statewide quality improvement projects for thousands of surgical patients in Illinois. Dr. McGee’s research interests include surgical quality improvement, implementation science, and patient education. He is an active member of several national surgical organizations, multiple editorial boards, and has authored over fifty publications and received multiple grants and awards for research, teaching, and humanism. Dr. Mcgee is rated as a Distinguished provider by MediFind in the treatment of Anal Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Familial Colorectal Cancer, Gastrointestinal Fistula, Colostomy, and Hernia Surgery. Dr. Mcgee is board certified in Surgery and Colon & Rectal Surgery.

John C. Byrn, M.D is a Clinical Professor of Surgery in the Division of Colorectal Surgery. He graduated from Hope College with a B.A. in Chemistry and received his MD degree from the University of Illinois-Chicago College of Medicine. He trained in general surgery at Mount Sinai School of Medicine in New York, NY. Dr. Byrn went on for his Colon and Rectal residency at the Cleveland Clinic, Cleveland, OH. Dr. Byrn was a Clinical Assistant and Associate Professor of Surgery at the University of Iowa Hospitals and Clinics from 2009-2015 and served as the Chief of the Section of Colorectal Surgery from 2013-2105. Dr. Byrn is rated as a Distinguished provider by MediFind in the treatment of Anal Cancer. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Rectal Prolapse, Familial Colorectal Cancer, Ileostomy, and Colostomy. Dr. Byrn is board certified in Surgery and Colon & Rectal Surgery.

Samantha Hendren is a General Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Hendren is rated as a Distinguished provider by MediFind in the treatment of Anal Cancer. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Anal Cancer, Ileostomy, and Colostomy.

Dr. Cuneo grew up in Northern California. He studied Biological and Environmental Engineering at Cornell University in Ithaca, NY. Dr. Cuneo received his Doctor of Medicine degree from Vanderbilt University School of Medicine in 2007 and completed an internship there in 2008. In 2008 he started his residency in Radiation Oncology at Duke University Medical Center. Dr. Cuneo has been an Assistant Professor in the Department of Radiation Oncology at the University of Michigan since 2012. Dr. Cuneo is rated as a Distinguished provider by MediFind in the treatment of Anal Cancer. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Pancreatic Cancer, Liposarcoma, Liver Cancer, and Pancreaticoduodenectomy. Dr. Cuneo is board certified in Radiation Oncology.

Dr. Daniel Chang is a nationally and internationally recognized expert in radiotherapy for GI malignancies. His primary research interest is in advanced radiotherapy techniques, primarily with stereotactic body radiotherapy (SBRT). He has led several studies investigating and establishing the efficacy and safety for SBRT for these diseases for liver and pancreatic tumors. His other research interests include normal tissue tolerances, quality of life after radiotherapy, and combining radiotherapy with targeted agents. In addition, he has a strong interest in the use of radiotherapy, particularly in combination with systemic agents, in patients with metastatic disease. Another area of interest is in health care utilization for patients with metastatic disease and using machine learning and other approaches to optimize care during the end-of-life period.Dr. Chang is interested in developing novel modalities and technologies for delivering radiotherapy. He previously led the FDA trial that led to approval of PET-guided radiotherapy, which in broader terms, is called Biology-guided radiotherapy. In addition, he has experience with MR-guided radiotherapy, and he is interested in exploring the role of particle therapy and heave ion radiotherapy.Dr. Chang received his MD from Wayne State University in 2002 and completed his residency in Radiation Oncology at the University of Florida in Gainesville, Florida in 2007. He then joined the Department of Radiation Oncology at Stanford University from 2007-2022, having previously served as residency program director from 2012-2017 and the Vice Chair of Clinical Operations from 2017-2022 where he was also the Sue and Bob McCollum Professor in Radiation Oncology.Dr. Chang is a member of the American Society of Radiation Oncology (ASTRO), American Radium Society (ARS), and the American Society of Clinical Oncology (ASCO). He serves on the scientific committee for ASTRO, ASCO, and GI ASCO. He has authored or co-authored over 190 peer-reviewed publications for journals including Journal of Clinical Oncology, Journal of the National Cancer Institute, Clinical Cancer Research, Radiology, International Journal of Radiation Oncology, Biology, and Physics, Radiotherapy and Oncology, and Cancer. He served as the senior editor for the GI section of the International Journal of Radiation Oncology, Biology, and Physics from 2013-2017 and is currently on the editorial board for Practical Radiation Oncologysince 2020. He served on the Hepatobiliary Panel for the National Cancer Comprehensive Network (NCCN) guidelines from 2013-2022, helping to shape national guidelines for the work-up, diagnosis, and treatment of patients with hepatobiliary cancers. He is currently the track chair for the GI track for the ASTRO Annual Meeting Scientific Committee. He also serves on the Education Committee for the Gastrointestinal Cancer - Gastroesophageal, Pancreatic, and Hepatobiliary Track for the ASCO annual meeting starting in 2023. Dr. Chang is rated as a Distinguished provider by MediFind in the treatment of Anal Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), and Familial Pancreatic Cancer. Dr. Chang is board certified in Radiation Oncology.

Dr. Zalupski is an Professor of Medicine in the division of Medical Oncology at the UMMC. He completed medical school, an internal medicine residency and a medical oncology fellowship at Wayne State University in Detroit. Dr. Zalupski's clinical and research interest is in experimental therapeutics of gastrointestinal malignancies and sarcomas. He also serves as the medical director of the Multidisciplinary Pancreatic Cancer Clinic. Dr. Zalupski is rated as a Distinguished provider by MediFind in the treatment of Anal Cancer. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, Familial Pancreatic Cancer, and Pancreaticoduodenectomy. Dr. Zalupski is board certified in Internal Medicine and Medical Oncology.

Scott Regenbogen, MD, MPH is a Professor of Surgery and Division Chief of Colorectal Surgery. He graduated from Princeton University with an A.B. in psychology, and received his M.D. degree from the University of California, San Francisco. He completed General Surgery residency at the Massachusetts General Hospital, including three years as a Postdoctoral Fellow in Health Services Research, and was awarded a Master’s in Public Health from the Harvard School of Public Health. He then completed fellowship training in Colon and Rectal Surgery at the Lahey Clinic, and joined the faculty of the University of Michigan in 2011.Clinical SpecializationDr. Regenbogen's clinical practice includes the evaluation and management of benign and neoplastic diseases of the small bowel, colon, rectum, and anus. He has a particular interest in the use of laparoscopic techniques for the management of colorectal cancer, diverticular disease and inflammatory bowel disease. Dr. Regenbogen is rated as an Advanced provider by MediFind in the treatment of Anal Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Anal Cancer, Ileostomy, and Hernia Surgery. Dr. Regenbogen is board certified in Surgery and Colon & Rectal Surgery.

Calista Harbaugh, M.D. M.Sc. is a faculty member in the Division of Colorectal Surgery. Dr. Harbaugh graduated Summa Cum Laude with a B.S.E. in Biomedical Engineering from the University of Michigan in Ann Arbor, Michigan. She went on to receive her medical degree from the University of Michigan School of Medicine with Alpha Omega Alpha honors. She then completed her internship and residency in General Surgery at the University of Michigan, including 2 years as a Clinician Scholar in the National Clinician Scholars Program at the University of Michigan where she earned her Master’s degree in Health and Healthcare Research. She completed the Colon & Rectal Surgery Fellowship at the University of Minnesota, and returned to the University of Michigan as an Assistant Professor of Surgery.Clinical Specialization: Dr. Harbaugh’s clinical practice includes the evaluation and management of benign and neoplastic diseases of the small bowel, colon, rectum, and anus. She has a particular interest in the use of laparoscopic and robotic techniques for the management of colorectal cancer, diverticular disease and inflammatory bowel disease. Dr. Harbaugh is rated as an Experienced provider by MediFind in the treatment of Anal Cancer. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Rectal Prolapse, Familial Colorectal Cancer, Colorectal Cancer, Hemorrhoidectomy, and Ureteroscopy. Dr. Harbaugh is board certified in Surgery and Colon & Rectal Surgery.

Nikita Consul is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Consul is rated as an Experienced provider by MediFind in the treatment of Anal Cancer. Her clinical expertise encompasses Giant Mammary Hamartoma, Liver Cancer, Bannayan-Riley-Ruvalcaba Syndrome, and Lhermitte-Duclos Disease. Dr. Consul is board certified in Diagnostic Radiology.

Thomas Regenbogen is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Regenbogen is rated as a Distinguished provider by MediFind in the treatment of Anal Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Anal Cancer, and Pleuropulmonary Blastoma.

Grace Chen is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Anal Cancer. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Gastroesophageal Junction Cancer, Colorectal Cancer, and Neuroendocrine Tumor. Dr. Chen is board certified in Medical Oncology and Internal Medicine.

James Shields is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Shields is rated as an Experienced provider by MediFind in the treatment of Anal Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Intussusception in Children, Retroperitoneal Fibrosis, Cerebral Arteriovenous Malformation, Urothelial Cancer, and Gastrostomy.

Mario Lacerna is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Lacerna is rated as an Experienced provider by MediFind in the treatment of Anal Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer. Dr. Lacerna is board certified in Radiation Oncology.

Terri Bott-Kothari, MD has been in practice for over 16 years treating all disease sites. She completed her medical training at Wayne State University School of Medicine and residency at the University of Cincinnati. Dr. Bott is rated as an Experienced provider by MediFind in the treatment of Anal Cancer. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Familial Prostate Cancer. Dr. Bott is board certified in Radiation Oncology.

I ride both a road bike and Peleton. I golf about 2-3 times per week. Have four grandchildren to dote on. I mostly fiction novels. Exercise twice per week. Dr. Terebelo is rated as an Experienced provider by MediFind in the treatment of Anal Cancer. He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Essential Thrombocythemia, Familial Colorectal Cancer, Bone Marrow Aspiration, and Tissue Biopsy.

Dr. Sofia Merajver received a doctoral degree in physics from the University of Maryland and a medical degree from the University of Michigan. She completed a residency in internal medicine and a fellowship in oncology at the University of Michigan before joining the faculty in 1994. Dr. Merajver, an expert in breast cancer genetics, is the medical director of the Breast and Ovarian Cancer Risk Evaluation Program at the U-M Rogel Cancer Center. Her research interests include the molecular genetics of breast cancer, gene function and cancer risk assessment. She enjoys literature, music and outdoor activities with her family. Dr. Merajver is rated as an Experienced provider by MediFind in the treatment of Anal Cancer. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, and Angiosarcoma. Dr. Merajver is board certified in Medical Oncology.

Dr. Veenstra earned her medical degree from Wayne State University in Detroit, Michigan and completed Internal Medicine internship and residency at the University of Michigan, where she also served as Chief Medical Resident. She completed her Medical Oncology fellowship training at the University of Pennsylvania, during which time she also earned a Masters in Health Policy Research. She joined the faculty at the University of Michigan in 2013.Dr. Veenstra’s research program focuses on the financial impacts of cancer diagnosis and treatment on patients and their families, the role of family in receipt of optimal cancer care, and issues facing cancer survivors. She currently holds a K07 Award from the National Cancer Institute to study the role of an engaged spouse or significant other in receipt of high quality surveillance care among survivors of colorectal cancer. Dr. Veenstra is rated as an Experienced provider by MediFind in the treatment of Anal Cancer. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Gastroesophageal Junction Cancer. Dr. Veenstra is board certified in Medical Oncology.

Imad Shureiqi is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Shureiqi is rated as an Experienced provider by MediFind in the treatment of Anal Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Pseudomyxoma Peritonei. Dr. Shureiqi is board certified in Medical Oncology.

Thomas Enzler, MD PhD, is an Assistant Professor in the Division of Hematology and Oncology. He received his Master of Science from ETH Zurich and his Medical Degree from University of Basel, Switzerland. After completion of residency in Internal Medicine at University Hospitals of Zurich and Basel, Dr. Enzler did a research fellowship at the Dana Farber Cancer Institute, Harvard Medical School, Boston. There, he worked on projects focusing on tumor immune surveillance and his work resulted in several publications and in a PhD ‘magna cum laude’ in Biochemistry/Immunology (Harvard Medical School Boston/Max Delbrueck Center Berlin). He then moved to University of California San Diego to study signaling pathways of cancer cells and immune cells. While there, he successfully obtained ECFMG certification prior to doing clinic and laboratory research at Stanford University. From California Dr. Enzler went to Germany to do a Hematology and Oncology fellowship at University of Goettingen and he received board certification in both in Germany and in Switzerland. Dr. Enzler decided to return to the U.S. and completed U.S. residency in Internal Medicine at University of Arizona in Tucson. Following U.S. residency training, Dr. Enzler completed fellowship in Hematology and Oncology at Columbia University Medical Center, New York, where he worked on several research projects on gastrointestinal cancers. Dr. Enzler is rated as an Experienced provider by MediFind in the treatment of Anal Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Familial Pancreatic Cancer, and Pancreatic Ductal Adenocarcinoma. Dr. Enzler is board certified in Internal Medicine, Medical Oncology, and Hematology.

Oxana Crysler is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Crysler is rated as an Experienced provider by MediFind in the treatment of Anal Cancer. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Familial Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Cholangiocarcinoma (Bile Duct Cancer). Dr. Crysler is board certified in Medical Oncology.